4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-054513
Chief Scientific Officer sold 3,000 shares at an average $69.79 ($209,377)
- Chief Scientific Officer acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Biller Scott Chief Scientific Officer | 2018-10-05 | Option exercise | +3,000 | $9.05 | $27,150 | 53,932 | D |
| Biller Scott Chief Scientific Officer | 2018-10-05 | Sale | −900 | $68.56 | $61,704 | 53,032 | D |
| Biller Scott Chief Scientific Officer | 2018-10-05 | Sale | −979 | $69.47 | $68,011 | 52,053 | D |
| Biller Scott Chief Scientific Officer | 2018-10-05 | Sale | −1,100 | $71.05 | $78,155 | 50,953 | D |
| Biller Scott Chief Scientific Officer | 2018-10-05 | Sale | −21 | $71.77 | $1,507 | 50,932 | D |
| Derivatives | |||||||
| Biller Scott Chief Scientific Officer | 2018-10-05 | Option exercise · Stock options (right to buy) | −3,000 | 7,154 | D | ||
| Open-market sales · 3,000 sh · avg $69.79 · $209,377 | |||||||
Loading xslF345X03/doc4.xml…